Suppr超能文献

青光眼医学管理的实用方法。

Practical approach to medical management of glaucoma.

作者信息

Parikh Rajul S, Parikh Shefali R, Navin Shoba, Arun Ellen, Thomas Ravi

机构信息

LV Prasad Eye Institute, Hyderabad, Andhra Pradesh, India.

出版信息

Indian J Ophthalmol. 2008 May-Jun;56(3):223-30. doi: 10.4103/0301-4738.40362.

Abstract

Primary open angle glaucoma (POAG) is usually a chronic, slowly progressive disease. At present, all resources are directed towards reduction of intraocular pressure (IOP), the only known causal and treatable risk factor for glaucoma, and medical management is frequently the first choice in most cases. With the introduction of innovative tools for early diagnosis and newer medications for treatment, decision-making in diagnosis and treatment of glaucoma has become more complex. The philosophy of glaucoma management is to preserve the visual function and quality of life (QOL) of the individual with minimum effects on QOL in terms of cost, side effects, treatment regime, follow-up schedules as well as socioeconomic burden. Our aim should be not to treat just the IOP, optic disc or visual field, but to treat the patient as a whole so as to provide maximum benefit with minimal side effects. In this article, we describe the scientific approach to medical management, mainly of POAG.

摘要

原发性开角型青光眼(POAG)通常是一种慢性、进展缓慢的疾病。目前,所有资源都致力于降低眼压(IOP),这是青光眼唯一已知的病因和可治疗的危险因素,在大多数情况下,药物治疗常常是首选。随着早期诊断创新工具的引入和治疗新药物的出现,青光眼的诊断和治疗决策变得更加复杂。青光眼管理的理念是在成本、副作用、治疗方案、随访计划以及社会经济负担方面对生活质量(QOL)影响最小的情况下,保护个体的视觉功能和生活质量。我们的目标不应仅仅是治疗眼压、视盘或视野,而应将患者作为一个整体进行治疗,以便在副作用最小的情况下提供最大益处。在本文中,我们描述了主要针对原发性开角型青光眼的药物治疗的科学方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72e2/2636120/f9851c1988e7/IndianJOphthalmol-56-223-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验